Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine Bolus Doses for Severe Post-spinal Hypotension in Cesarean Delivery
NCT05290740Phase 4Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Mar 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of norepinephrine in hypotension, sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence of successful management of severe post-spinal hypotension at 2 minutes. Started Mar 2022; status: completed.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05290740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05290740.